A Alencar

572 total citations
37 papers, 442 citations indexed

About

A Alencar is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology. According to data from OpenAlex, A Alencar has authored 37 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Obstetrics and Gynecology. Recurrent topics in A Alencar's work include Pulmonary Hypertension Research and Treatments (10 papers), Pregnancy and preeclampsia studies (5 papers) and Cardiovascular Function and Risk Factors (5 papers). A Alencar is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Pregnancy and preeclampsia studies (5 papers) and Cardiovascular Function and Risk Factors (5 papers). A Alencar collaborates with scholars based in Brazil, United States and Chile. A Alencar's co-authors include Gisele Zapata‐Sudo, Roberto T. Sudo, Hao Wang, Leanne Groban, Tadeu L. Montagnoli, Eliezer J. Barreiro, Jaqueline da Silva, Xuming Sun, Marina Lin and Carlos Alberto Manssour Fraga and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

A Alencar

33 papers receiving 432 citations

Peers

A Alencar
Tracy Clarke United States
Xinkai Qu China
Neel Patel United States
Mohammed Mamdani United States
Jennifer Kleinhenz United States
W Uracz Poland
A Alencar
Citations per year, relative to A Alencar A Alencar (= 1×) peers Jiangtao Yan

Countries citing papers authored by A Alencar

Since Specialization
Citations

This map shows the geographic impact of A Alencar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Alencar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Alencar more than expected).

Fields of papers citing papers by A Alencar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Alencar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Alencar. The network helps show where A Alencar may publish in the future.

Co-authorship network of co-authors of A Alencar

This figure shows the co-authorship network connecting the top 25 collaborators of A Alencar. A scholar is included among the top collaborators of A Alencar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Alencar. A Alencar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Lili, A Alencar, Kenneth F. Swan, et al.. (2025). Homodyned K-Distribution Temporal-Based Characterization of Rat Placenta Microstructure Using the Reduced Uterine Perfusion Pressure Model of Preeclampsia. Ultrasound in Medicine & Biology. 51(7). 1090–1101.
2.
Shi, Lili, et al.. (2025). Quantifying Molecular Changes in the Preeclamptic Rat Placenta with Targeted Contrast-Enhanced Ultrasound Imaging. Molecular Imaging and Biology. 27(2). 274–284.
3.
Alencar, A, Kenneth F. Swan, Lili Shi, et al.. (2025). Quantitative Ultrasound-Based Characterization of Placental Tissue Microstructure in a Rat Model of Preeclampsia. Ultrasound in Medicine & Biology. 51(8). 1298–1307.
4.
Rodrigues‐da‐Silva, Rodrigo Nunes, Letusa Albrecht, Kézia Katiani Gorza Scopel, et al.. (2024). Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities. Scientific Reports. 14(1). 27343–27343.
5.
Alencar, A, et al.. (2023). Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals. 16(2). 148–148. 35 indexed citations
6.
Alencar, A, Kenneth F. Swan, Gabriella Pridjian, Sarah H. Lindsey, & Carolyn L. Bayer. (2023). Connecting G protein-coupled estrogen receptor biomolecular mechanisms with the pathophysiology of preeclampsia: a review. Reproductive Biology and Endocrinology. 21(1). 60–60. 3 indexed citations
7.
Alencar, A, Hao Wang, Gláucia Maria Moraes de Oliveira, et al.. (2021). Relações entre a Redução de Estrogênio, Obesidade e Insuficiência Cardíaca com Fração de Ejeção Preservada. Arquivos Brasileiros de Cardiologia. 117(6). 1191–1201. 2 indexed citations
8.
Montagnoli, Tadeu L., Jaqueline da Silva, A Alencar, et al.. (2020). <p>New Benzofuran <em>N</em>-Acylhydrazone Reduces Cardiovascular Dysfunction in Obese Rats by Blocking TNF-Alpha Synthesis</p>. Drug Design Development and Therapy. Volume 14. 3337–3350. 6 indexed citations
10.
Alencar, A, Margarete M. Trachez, Jaqueline da Silva, et al.. (2019). Reduction of cardiac and renal dysfunction by new inhibitor of DPP4 in diabetic rats. Pharmacological Reports. 71(6). 1190–1200. 6 indexed citations
11.
Alencar, A, Sabrina Teixeira Martinez, Carlos Alberto Manssour Fraga, et al.. (2018). Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats. PLoS ONE. 13(4). e0195047–e0195047. 9 indexed citations
12.
Alencar, A, Pedro M. Pimentel‐Coelho, Tadeu L. Montagnoli, et al.. (2018). Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice. Frontiers in Pharmacology. 9. 1395–1395. 25 indexed citations
13.
Alencar, A, Tadeu L. Montagnoli, Sabrina Teixeira Martinez, et al.. (2016). Activation of GPER ameliorates experimental pulmonary hypertension in male rats. European Journal of Pharmaceutical Sciences. 97. 208–217. 35 indexed citations
14.
Alencar, A, Jaqueline da Silva, Marina Lin, et al.. (2016). Effect of Age, Estrogen Status, and Late-Life GPER Activation on Cardiac Structure and Function in the Fischer344×Brown Norway Female Rat. The Journals of Gerontology Series A. 72(2). 152–162. 46 indexed citations
15.
Wang, Hao, A Alencar, Marina Lin, et al.. (2016). Activation of GPR30 improves exercise capacity and skeletal muscle strength in senescent female Fischer344 × Brown Norway rats. Biochemical and Biophysical Research Communications. 475(1). 81–86. 14 indexed citations
16.
Alencar, A, Sharlene Lopes Pereira, Tadeu L. Montagnoli, et al.. (2013). Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline‐induced pulmonary hypertension in rats. British Journal of Pharmacology. 169(5). 953–962. 38 indexed citations
17.
Costa, Salvatore, et al.. (1984). Role of T lymphocytes in the resistance and immunopathology of experimental chagas' disease. Annales de l Institut Pasteur Immunologie. 135(3). 317–332. 24 indexed citations
18.
Alencar, A. (1964). [CORTICAL ATROPHY IN CHRONIC CHAGASIC CARDIOPATHY].. PubMed. 66. 807–15. 2 indexed citations
19.
Alencar, A. (1964). [CLINICAL AND BIOLOGICAL ASPECTS OF NEUROLOGICAL AND MUSCULAR MANIFESTATIONS OF SOUTH AMERICAN TRYPANOSOMIASIS (CHAGAS' DISEASE)].. PubMed. 27. 57–69. 1 indexed citations
20.
Alencar, A, et al.. (1963). [METASTATIC TUMORS OF THE CENTRAL NERVOUS SYSTEM].. PubMed. 15. 17–45. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026